ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ViiV’s Rukobia receives marketing authorisation in Europe for HIV treatment
February 10, 2021GlaxoSmithKline’s (GSK) ViiV Healthcare has announced the European Marketing Authorisation of its Rukobia (fostemsavir) 600mg extended-release tablets for use in combination with antiretroviral (ARV) therapies for treating adults with ... -
ViiV Healthcare seeks EMA approval for HIV-1 drug candidate fostemsavir
January 15, 2020ViiV Healthcare has completed a regulatory filing in Europe seeking the approval for fostemsavir for the treatment of HIV-1 infection in adult patients having limited treatment options. -
ViiV Healthcare seeks FDA approval for fostemsavir to treat HIV-1 infection
December 11, 2019ViiV Healthcare is seeking approval from the US Food and Drug Administration (FDA) for its fostemsavir to treat HIV-1 infection.
Pharma Sources Insight January 2025
